ClearPoint Neuro
CLPT
67 hedge funds and large institutions have $53.4M invested in ClearPoint Neuro in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 19 closing their positions.
143% more call options, than puts
Call options by funds: $1.96M | Put options by funds: $806K
18% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 17
3% less funds holding
Funds holding: 69 → 67 (-2)
4.35% less ownership
Funds ownership: 24.53% → 20.18% (-4.4%)
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
45% less capital invested
Capital invested by funds: $97.5M → $53.4M (-$44.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$2M |
| 2 |
Morgan Stanley
New York
|
+$1.7M |
| 3 |
Renaissance Technologies
New York
|
+$1.25M |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$1.05M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$963K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$8.93M |
| 2 |
FAM
Fred Alger Management
New York
|
-$3.38M |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$2.73M |
| 4 |
GPC
Guardian Point Capital
Charlottesville,
Virginia
|
-$1.95M |
| 5 |
CCM
Conway Capital Management
Burbank,
California
|
-$1.13M |
CLPT Hedge Fund Activity: Q4 2021 in Review
67 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q4 2021, worth a combined $53.4M — down 45% from $97.5M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CLPT and 17 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 20 added.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $2M. The largest seller was Royce & Associates, cutting an estimated $8.93M.
- 67 institutional investors held ClearPoint Neuro (CLPT) as of Q4 2021, down from 69 in Q3 2021.
- Funds reported $53.4M of ClearPoint Neuro stock for Q4 2021, down 45% quarter-over-quarter.
- 17 funds opened new ClearPoint Neuro positions in Q4 2021 and 19 closed out, a net change of -2 holders.
- The largest ClearPoint Neuro buyer in Q4 2021 was Two Sigma Investments, an estimated $2M added.
- The largest ClearPoint Neuro seller in Q4 2021 was Royce & Associates, an estimated $8.93M sold.
Based on aggregated 13F filings for Q4 2021.